- Motus GI (NASDAQ:MOTS) stock is our biggest winner this morning.
- Verrica Pharmaceuticals (NASDAQ:VRCA) shares lead our losers today.
- Wendy’s (NASDAQ:WEN) is rising on acquisition talks.
Source: f11photo/Shutterstock.com
We’re starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!
There’s plenty of news moving stocks today. Among that is a clinical trial, summer travel plans, and more.
Let’s jump into that news below!
Pre-Ҵý Stock Movers: 10 Top Gainers
- Motus GI (NASDAQ:MOTS) stock is rocketing more than 46% .
- Genocea Biosciences (NASDAQ:GNCA) shares are soaring over 42% .
- Singing Machine (NASDAQ:MICS) stock is surging more than 31 % .
- ShiftPixy (NASDAQ:PIXY) shares are gaining over 25% after announcing .
- Trivago (NASDAQ:TRVG) stock is moving more than 13% higher after .
- AcelRx Pharmaceuticals (NASDAQ:ACRX) shares are rising roughly 13% .
- American Rebel Holdings (NASDAQ:AREB) stock is increasing over 11% after the gun safe stock’s shares dropped following yesterday’s shooting.
- Wendy’s (NASDAQ:WEN) shares are climbing more than 11% .
- Momentus (NASDAQ:MNTS) stock is jumping over 11% .
- VNET (NASDAQ:VNET) shares are up more than 10% .
10 Top Losers
- Verrica Pharmaceuticals (NASDAQ:VRCA) stock is plummeting about 55% .
- SciSparc (NASDAQ:SPRC) stock is tumbling over 11% .
- Catalyst Biosciences (NASDAQ:CBIO) shares are taking a more than 9% beating after rallying on an asset sale Tuesday.
- Kala Pharmaceuticals (NASDAQ:KALA) stock is dropping over 9%, .
- Predictive Oncology (NASDAQ:POAI) shares are falling 9% .
- Molecular Data (NASDAQ:MKD) stock is decreasing around 8% .
- Aurora Mobile (NASDAQ:JG) shares are declining more than 7% on no clear news this morning.
- BIMI International Medical (NASDAQ:BIMI) stock is slipping close to 7% following a recent rally.
- Zovio (NASDAQ:ZVO) shares are dipping over 6% after .
- Fast Radius (NASDAQ:FSRD) stock closes out our pre-market stock movers down more than 6%.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.